Correlation Between Tarsus Pharmaceuticals and Mountain Crest
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Mountain Crest at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Mountain Crest into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Mountain Crest Acquisition, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Mountain Crest and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Mountain Crest. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Mountain Crest.
Diversification Opportunities for Tarsus Pharmaceuticals and Mountain Crest
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Tarsus and Mountain is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Mountain Crest Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mountain Crest Acqui and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Mountain Crest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mountain Crest Acqui has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Mountain Crest go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Mountain Crest
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.57 times more return on investment than Mountain Crest. However, Tarsus Pharmaceuticals is 1.74 times less risky than Mountain Crest. It trades about 0.15 of its potential returns per unit of risk. Mountain Crest Acquisition is currently generating about -0.28 per unit of risk. If you would invest 2,884 in Tarsus Pharmaceuticals on September 15, 2024 and sell it today you would earn a total of 2,366 from holding Tarsus Pharmaceuticals or generate 82.04% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 15.08% |
Values | Daily Returns |
Tarsus Pharmaceuticals vs. Mountain Crest Acquisition
Performance |
Timeline |
Tarsus Pharmaceuticals |
Mountain Crest Acqui |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Tarsus Pharmaceuticals and Mountain Crest Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tarsus Pharmaceuticals and Mountain Crest
The main advantage of trading using opposite Tarsus Pharmaceuticals and Mountain Crest positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Mountain Crest can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mountain Crest will offset losses from the drop in Mountain Crest's long position.Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Mountain Crest vs. Lipocine | Mountain Crest vs. Spyre Therapeutics | Mountain Crest vs. Tarsus Pharmaceuticals | Mountain Crest vs. Comstock Holding Companies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |